speb/financial-data huggingface dataset:
VS income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 2937423.00
VS cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 8919002.00
VS income_statement (annual, 2022-12-31) — Basic Average Shares: 103773.00
VS income_statement (annual, 2022-12-31) — Basic EPS: -192.89
VS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1678156.00
VS cash_flow (annual, 2022-12-31) — Capital Expenditure: -2536832.00
VS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 128560.00
VS balance_sheet (annual, 2022-12-31) — Capital Stock: 136888530.00
VS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1178847.00
VS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1178847.00
VS balance_sheet (annual, 2022-12-31) — Cash Financial: 1178847.00
VS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 11191067.00
VS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2536832.00
VS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -9153544.00
VS cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -124231.00
VS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -61112.00
VS cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 154700.00
VS cash_flow (annual, 2022-12-31) — Change In Receivables: 62868.00
VS cash_flow (annual, 2022-12-31) — Change In Working Capital: 32225.00
VS cash_flow (annual, 2022-12-31) — Changes In Cash: -499309.00
VS balance_sheet (annual, 2022-12-31) — Common Stock: 136888530.00
VS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 11136475.00
VS cash_flow (annual, 2022-12-31) — Common Stock Issuance: 13251733.00
VS income_statement (annual, 2022-12-31) — Cost Of Revenue: 617049.00
VS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 79113.00
VS balance_sheet (annual, 2022-12-31) — Current Assets: 1462822.00
VS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 128560.00
VS balance_sheet (annual, 2022-12-31) — Current Debt: 2604713.00
VS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2733273.00
VS balance_sheet (annual, 2022-12-31) — Current Deferred Assets: 0.00
VS balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 69275.00
VS balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 69275.00
VS balance_sheet (annual, 2022-12-31) — Current Liabilities: 3324560.00
VS balance_sheet (annual, 2022-12-31) — Current Notes Payable: 2604713.00
VS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3030966.00
VS income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 3210732.00
VS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3030966.00
VS income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 3210732.00
VS income_statement (annual, 2022-12-31) — Depreciation Income Statement: 273309.00
VS balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
VS income_statement (annual, 2022-12-31) — Diluted Average Shares: 103773.00
VS income_statement (annual, 2022-12-31) — Diluted EPS: -192.89
VS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -22473192.00
VS balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 304623.00
VS income_statement (annual, 2022-12-31) — EBIT: -13752343.00
VS income_statement (annual, 2022-12-31) — EBITDA: -10721377.00
VS cash_flow (annual, 2022-12-31) — End Cash Position: 1178847.00
VS cash_flow (annual, 2022-12-31) — Financing Cash Flow: 11191067.00
VS balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: 154970.00
VS cash_flow (annual, 2022-12-31) — Free Cash Flow: -11690376.00
VS cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -361055.00
VS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
VS income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 361055.00
VS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 154970.00
VS income_statement (annual, 2022-12-31) — General And Administrative Expense: 10406275.00
VS balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
VS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 6393364.00
VS balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 52692.00
VS balance_sheet (annual, 2022-12-31) — Gross PPE: 995921.00
VS income_statement (annual, 2022-12-31) — Gross Profit: 491791.00
VS income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 8919002.00
VS income_statement (annual, 2022-12-31) — Interest Expense: 122992.00
VS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 122992.00
VS balance_sheet (annual, 2022-12-31) — Invested Capital: 13741188.00
VS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2536832.00
VS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 13251733.00
VS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
VS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
VS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
VS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
VS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -260185.00
VS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 246719.00
VS balance_sheet (annual, 2022-12-31) — Minority Interest: -6402387.00
VS cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
VS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 13251733.00
VS balance_sheet (annual, 2022-12-31) — Net Debt: 1425866.00
VS cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 70157.00
VS income_statement (annual, 2022-12-31) — Net Income: -22473192.00
VS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -22473192.00
VS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -22473192.00
VS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -22473192.00
VS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -22473192.00
VS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -22473192.00
VS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -22473192.00
VS cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -2496621.00
VS income_statement (annual, 2022-12-31) — Net Interest Income: -183762.00
VS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 0.00
VS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -324004.00
VS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -260185.00
VS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -183762.00
VS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1736662.00
VS balance_sheet (annual, 2022-12-31) — Net PPE: 93973.00
VS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -40211.00
VS cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -63819.00
VS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 4743111.00
VS balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 100000.00
VS income_statement (annual, 2022-12-31) — Normalized EBITDA: -2163430.00
VS income_statement (annual, 2022-12-31) — Normalized Income: -13915245.00
VS cash_flow (annual, 2022-12-31) — Operating Cash Flow: -9153544.00
VS cash_flow (annual, 2022-12-31) — Operating Gains Losses: -290898.00
VS income_statement (annual, 2022-12-31) — Operating Income: -13752343.00
VS income_statement (annual, 2022-12-31) — Operating Revenue: 1108840.00
VS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 260760.00
VS balance_sheet (annual, 2022-12-31) — Other Current Assets: 223226.00
VS balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 2604713.00
VS balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 154970.00
VS income_statement (annual, 2022-12-31) — Other Gand A: 2914910.00
VS income_statement (annual, 2022-12-31) — Other Income Expense: -8720849.00
VS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 6393364.00
VS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 60770.00
VS balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 8489.00
VS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -162902.00
VS income_statement (annual, 2022-12-31) — Other Operating Expenses: 1079387.00
VS balance_sheet (annual, 2022-12-31) — Other Properties: 749202.00
VS balance_sheet (annual, 2022-12-31) — Payables: 442899.00
VS balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 522012.00
VS income_statement (annual, 2022-12-31) — Pretax Income: -22473192.00
VS cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
VS cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
VS cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -2496621.00
VS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -40211.00
VS balance_sheet (annual, 2022-12-31) — Receivables: 60749.00
VS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 617049.00
VS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 3030966.00
VS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -324004.00
VS income_statement (annual, 2022-12-31) — Research And Development: 2406006.00
VS balance_sheet (annual, 2022-12-31) — Retained Earnings: -125907025.00
VS income_statement (annual, 2022-12-31) — Salaries And Wages: 0.00
VS cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
VS cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
VS income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 11838128.00
VS income_statement (annual, 2022-12-31) — Selling General And Administration: 11838128.00
VS balance_sheet (annual, 2022-12-31) — Share Issued: 260760.00
VS cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -63819.00
VS income_statement (annual, 2022-12-31) — Special Income Charges: -8919002.00
VS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1567583.00
VS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 11136475.00
VS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 4743111.00
VS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
VS income_statement (annual, 2022-12-31) — Tax Provision: 0.00
VS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
VS balance_sheet (annual, 2022-12-31) — Taxes Receivable: 14157.00
VS balance_sheet (annual, 2022-12-31) — Total Assets: 8058648.00
VS balance_sheet (annual, 2022-12-31) — Total Capitalization: 11136475.00
VS balance_sheet (annual, 2022-12-31) — Total Debt: 2733273.00
VS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 4734088.00
VS income_statement (annual, 2022-12-31) — Total Expenses: 14861183.00
VS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3324560.00
VS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6595826.00
VS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
VS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -22671345.00
VS income_statement (annual, 2022-12-31) — Total Other Finance Cost: 60770.00
VS income_statement (annual, 2022-12-31) — Total Unusual Items: -8557947.00
VS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -8557947.00
VS balance_sheet (annual, 2022-12-31) — Working Capital: -1861738.00
VS income_statement (annual, 2023-12-31) — +Operating Expense: 6698039.00
VS income_statement (annual, 2023-12-31) — +Total Revenue: 271169.00
VS balance_sheet (annual, 2023-12-31) — Accounts Payable: 82579.00
VS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 18222.00
VS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -22316.00
VS balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -2700.00
VS cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 2444445.00
VS cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 2444445.00
VS cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 3968332.00
VS income_statement (annual, 2023-12-31) — Basic Average Shares: 912717.00
VS income_statement (annual, 2023-12-31) — Basic EPS: -10.44
VS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1178847.00
VS cash_flow (annual, 2023-12-31) — Capital Expenditure: -19413.00
VS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 0.00
VS balance_sheet (annual, 2023-12-31) — Capital Stock: 147130123.00
VS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 4689007.00
VS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 4689007.00
VS balance_sheet (annual, 2023-12-31) — Cash Financial: 4689007.00
VS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 9045578.00
VS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -14514.00
VS cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -5582139.00
VS cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -34226.00
VS cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -239073.00
VS cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 162752.00
VS cash_flow (annual, 2023-12-31) — Change In Receivables: 42527.00
VS cash_flow (annual, 2023-12-31) — Change In Working Capital: -68020.00
VS cash_flow (annual, 2023-12-31) — Changes In Cash: 3448925.00
VS balance_sheet (annual, 2023-12-31) — Common Stock: 147130123.00
VS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 11944388.00
VS cash_flow (annual, 2023-12-31) — Common Stock Issuance: 7812663.00
VS income_statement (annual, 2023-12-31) — Cost Of Revenue: 103067.00
VS balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 26348.00
VS balance_sheet (annual, 2023-12-31) — Current Assets: 4867703.00
VS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 0.00
VS balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 35049.00
VS balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 35049.00
VS balance_sheet (annual, 2023-12-31) — Current Liabilities: 321476.00
VS balance_sheet (annual, 2023-12-31) — Current Notes Payable: 0.00
VS cash_flow (annual, 2023-12-31) — Depreciation: 23754.00
VS cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2468199.00
VS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2468199.00
VS income_statement (annual, 2023-12-31) — Diluted Average Shares: 912717.00
VS income_statement (annual, 2023-12-31) — Diluted EPS: -10.44
VS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -9526997.00
VS balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 177500.00
VS income_statement (annual, 2023-12-31) — EBIT: -6529937.00
VS income_statement (annual, 2023-12-31) — EBITDA: -4061738.00
VS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 61235.00
VS cash_flow (annual, 2023-12-31) — End Cash Position: 4689007.00
VS cash_flow (annual, 2023-12-31) — Financing Cash Flow: 9045578.00
VS cash_flow (annual, 2023-12-31) — Free Cash Flow: -5601552.00
VS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 63385.00
VS balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 248287.00
VS income_statement (annual, 2023-12-31) — General And Administrative Expense: 5590804.00
VS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 0.00
VS balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 11380.00
VS balance_sheet (annual, 2023-12-31) — Gross PPE: 24251.00
VS income_statement (annual, 2023-12-31) — Gross Profit: 168102.00
VS income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 3968332.00
VS cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
VS cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
VS balance_sheet (annual, 2023-12-31) — Invested Capital: 11944388.00
VS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -14514.00
VS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 7812663.00
VS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
VS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -128560.00
VS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 24251.00
VS balance_sheet (annual, 2023-12-31) — Minority Interest: -7387547.00
VS income_statement (annual, 2023-12-31) — Minority Interests: 985160.00
VS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 7812663.00
VS cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 61235.00
VS income_statement (annual, 2023-12-31) — Net Income: -9526997.00
VS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -9526997.00
VS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -10512157.00
VS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -9526997.00
VS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -9526997.00
VS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -10512157.00
VS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -10512157.00
VS cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -19413.00
VS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -2648395.00
VS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -128560.00
VS cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -679890.00
VS balance_sheet (annual, 2023-12-31) — Net PPE: 1935.00
VS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 4899.00
VS cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -2519835.00
VS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 11944388.00
VS balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 0.00
VS income_statement (annual, 2023-12-31) — Normalized EBITDA: -93406.00
VS income_statement (annual, 2023-12-31) — Normalized Income: -5558665.00
VS cash_flow (annual, 2023-12-31) — Operating Cash Flow: -5582139.00
VS cash_flow (annual, 2023-12-31) — Operating Gains Losses: 13887.00
VS income_statement (annual, 2023-12-31) — Operating Income: -6529937.00
VS income_statement (annual, 2023-12-31) — Operating Revenue: 271169.00
VS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 2506015.00
VS balance_sheet (annual, 2023-12-31) — Other Current Assets: 160474.00
VS balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 248287.00
VS income_statement (annual, 2023-12-31) — Other Gand A: 5944909.00
VS income_statement (annual, 2023-12-31) — Other Income Expense: -3982220.00
VS balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 8679.00
VS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -13888.00
VS balance_sheet (annual, 2023-12-31) — Other Properties: 749202.00
VS balance_sheet (annual, 2023-12-31) — Payables: 260079.00
VS balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 286427.00
VS income_statement (annual, 2023-12-31) — Pretax Income: -10512157.00
VS cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 4561200.00
VS cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -19413.00
VS cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
VS balance_sheet (annual, 2023-12-31) — Receivables: 18222.00
VS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 103067.00
VS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2468199.00
VS cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2648395.00
VS income_statement (annual, 2023-12-31) — Research And Development: 1107235.00
VS balance_sheet (annual, 2023-12-31) — Retained Earnings: -135434022.00
VS income_statement (annual, 2023-12-31) — Salaries And Wages: -354105.00
VS cash_flow (annual, 2023-12-31) — Sale Of PPE: 4899.00
VS income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 5944909.00
VS income_statement (annual, 2023-12-31) — Selling General And Administration: 5590804.00
VS balance_sheet (annual, 2023-12-31) — Share Issued: 2506015.00
VS cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 0.00
VS cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -2519835.00
VS income_statement (annual, 2023-12-31) — Special Income Charges: -3968332.00
VS cash_flow (annual, 2023-12-31) — Stock Based Compensation: -1452380.00
VS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 11944388.00
VS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 11944388.00
VS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
VS income_statement (annual, 2023-12-31) — Tax Provision: 0.00
VS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
VS balance_sheet (annual, 2023-12-31) — Taxes Receivable: 9542.00
VS balance_sheet (annual, 2023-12-31) — Total Assets: 4878317.00
VS balance_sheet (annual, 2023-12-31) — Total Capitalization: 11944388.00
VS balance_sheet (annual, 2023-12-31) — Total Debt: 0.00
VS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 4556841.00
VS income_statement (annual, 2023-12-31) — Total Expenses: 6801106.00
VS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 321476.00
VS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 10614.00
VS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
VS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -10852374.00
VS income_statement (annual, 2023-12-31) — Total Unusual Items: -3968332.00
VS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3968332.00
VS balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
VS balance_sheet (annual, 2023-12-31) — Working Capital: 4546227.00
VS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 0.00
VS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 754.00
VS balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -24004.00
VS cash_flow (quarterly, 2024-09-30) — Amortization Cash Flow: 1688.00
VS cash_flow (quarterly, 2024-09-30) — Amortization Of Intangibles: 1688.00
VS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 2506015.00
VS income_statement (quarterly, 2024-09-30) — Basic EPS: -0.22
VS cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Financing Activities: 0.00
VS cash_flow (quarterly, 2024-09-30) — Cash Flow From Continuing Investing Activities: 0.00
VS cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: -8167.00
VS cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 9496.00
VS cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
VS balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 25783.00
VS balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 1164.00
VS balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 1164.00
VS cash_flow (quarterly, 2024-09-30) — Depreciation Amortization Depletion: 1688.00
VS cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 1688.00
VS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 2506015.00
VS income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.22
VS balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 0.00
VS cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: 0.00
VS cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
VS income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 521410.00
VS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 24004.00
VS cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: 0.00
VS cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
VS cash_flow (quarterly, 2024-09-30) — Long Term Debt Payments: 0.00
VS balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 24004.00
VS cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
VS cash_flow (quarterly, 2024-09-30) — Net Intangibles Purchase And Sale: 0.00
VS cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
VS cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
VS balance_sheet (quarterly, 2024-09-30) — Net PPE: 0.00
VS cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
VS income_statement (quarterly, 2024-09-30) — Other Gand A: 521410.00
VS income_statement (quarterly, 2024-09-30) — Other Income Expense: 73.00
VS income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 73.00
VS balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 770935.00
VS cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
VS cash_flow (quarterly, 2024-09-30) — Purchase Of Intangibles: 0.00
VS income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 1688.00
VS cash_flow (quarterly, 2024-09-30) — Repayment Of Debt: 0.00
VS income_statement (quarterly, 2024-09-30) — Salaries And Wages: 0.00
VS cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
VS income_statement (annual, 2024-12-31) — +Operating Expense: 4556237.00
VS income_statement (annual, 2024-12-31) — +Total Revenue: 57288.00
VS balance_sheet (annual, 2024-12-31) — Accounts Payable: 26288.00
VS balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 26288.00
VS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 0.00
VS balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 0.00
VS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -24004.00
VS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -24004.00
VS cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 0.00
VS cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: -1688.00
VS cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 0.00
VS cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: -1688.00
VS cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
VS income_statement (annual, 2024-12-31) — Basic Average Shares: 2628226.00
VS income_statement (annual, 2024-12-31) — Basic EPS: -1.54
VS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4689007.00
VS balance_sheet (annual, 2024-12-31) — Capital Stock: 150587018.00
VS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 3065914.00
VS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3065914.00
VS balance_sheet (annual, 2024-12-31) — Cash Financial: 3065914.00
VS balance_sheet (quarterly, 2024-12-31) — Cash Financial: 3065914.00
VS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3278235.00
VS cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3278235.00
VS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
VS cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: 0.00
VS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -4971948.00
VS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -35049.00
VS cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -1164.00
VS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -260140.00
VS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -300493.00
VS cash_flow (annual, 2024-12-31) — Change In Receivables: 18222.00
VS cash_flow (annual, 2024-12-31) — Change In Working Capital: -577460.00
VS cash_flow (annual, 2024-12-31) — Changes In Cash: -1693713.00
VS balance_sheet (annual, 2024-12-31) — Common Stock: 150587018.00
VS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 11429324.00
VS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
VS cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
VS income_statement (annual, 2024-12-31) — Cost Of Revenue: 40277.00
VS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 0.00
VS balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 0.00
VS balance_sheet (annual, 2024-12-31) — Current Assets: 3535560.00
VS balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 0.00
VS balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 0.00
VS balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 0.00
VS balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 0.00
VS balance_sheet (annual, 2024-12-31) — Current Liabilities: 26288.00
VS cash_flow (annual, 2024-12-31) — Depreciation: 1688.00
VS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1688.00
VS cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 0.00
VS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1688.00
VS cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 0.00
VS income_statement (annual, 2024-12-31) — Diluted Average Shares: 2628226.00
VS income_statement (annual, 2024-12-31) — Diluted EPS: -1.54
VS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -4042331.00
VS balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 0.00
VS balance_sheet (quarterly, 2024-12-31) — Dueto Related Parties Current: 0.00
VS income_statement (annual, 2024-12-31) — EBIT: -4539226.00
VS income_statement (annual, 2024-12-31) — EBITDA: -4537538.00
VS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 70620.00
VS cash_flow (annual, 2024-12-31) — End Cash Position: 3065914.00
VS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 3278235.00
VS cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 3278235.00
VS cash_flow (annual, 2024-12-31) — Free Cash Flow: -4971948.00
VS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
VS cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
VS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 318659.00
VS income_statement (annual, 2024-12-31) — General And Administrative Expense: 4310218.00
VS income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 881156.00
VS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
VS balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
VS balance_sheet (annual, 2024-12-31) — Gross PPE: 24004.00
VS balance_sheet (quarterly, 2024-12-31) — Gross PPE: 24004.00
VS income_statement (annual, 2024-12-31) — Gross Profit: 17011.00
VS income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
VS cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
VS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 0.00
VS balance_sheet (annual, 2024-12-31) — Invested Capital: 11429324.00
VS cash_flow (annual, 2024-12-31) — Investing Cash Flow: 0.00
VS cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: 0.00
VS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
VS cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
VS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 2500000.00
VS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
VS cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
VS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 24004.00
VS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 24004.00
VS balance_sheet (annual, 2024-12-31) — Minority Interest: -7920052.00
VS income_statement (annual, 2024-12-31) — Minority Interests: 532505.00
VS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
VS cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
VS income_statement (annual, 2024-12-31) — Net Income: -4042331.00
VS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -4042331.00
VS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -4574836.00
VS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -4042331.00
VS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -4042331.00
VS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -4574836.00
VS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -4574836.00
VS cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
VS cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
VS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 2500000.00
VS cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 2500000.00
VS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
VS cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
VS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -106768.00
VS balance_sheet (annual, 2024-12-31) — Net PPE: 0.00
VS balance_sheet (quarterly, 2024-12-31) — Net PPE: 0.00
VS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
VS cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
VS cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 2500000.00
VS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 11429324.00
VS income_statement (annual, 2024-12-31) — Normalized EBITDA: -4537538.00
VS income_statement (annual, 2024-12-31) — Normalized Income: -4042331.00
VS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -4971948.00
VS income_statement (annual, 2024-12-31) — Operating Income: -4539226.00
VS income_statement (annual, 2024-12-31) — Operating Revenue: 57288.00
VS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4901677.00
VS balance_sheet (annual, 2024-12-31) — Other Current Assets: 469646.00
VS balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 469646.00
VS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 318659.00
VS balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: 318659.00
VS income_statement (annual, 2024-12-31) — Other Gand A: 4310218.00
VS income_statement (quarterly, 2024-12-31) — Other Gand A: 881156.00
VS income_statement (annual, 2024-12-31) — Other Income Expense: -11384.00
VS income_statement (quarterly, 2024-12-31) — Other Income Expense: -11136.00
VS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 17795.00
VS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -11384.00
VS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -11136.00
VS balance_sheet (annual, 2024-12-31) — Payables: 26288.00
VS balance_sheet (quarterly, 2024-12-31) — Payables: 26288.00
VS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 26288.00
VS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 469646.00
VS balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 469646.00
VS income_statement (annual, 2024-12-31) — Pretax Income: -4550610.00
VS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 885003.00
VS cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 885003.00
VS cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
VS cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: 0.00
VS balance_sheet (annual, 2024-12-31) — Receivables: 0.00
VS balance_sheet (quarterly, 2024-12-31) — Receivables: 0.00
VS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 40277.00
VS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1688.00
VS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 0.00
VS cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
VS cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
VS income_statement (annual, 2024-12-31) — Research And Development: 246019.00
VS balance_sheet (annual, 2024-12-31) — Retained Earnings: -139476353.00
VS income_statement (annual, 2024-12-31) — Salaries And Wages: 0.00
VS income_statement (quarterly, 2024-12-31) — Salaries And Wages: 0.00
VS cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
VS cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
VS income_statement (annual, 2024-12-31) — Selling General And Administration: 4310218.00
VS balance_sheet (annual, 2024-12-31) — Share Issued: 4901677.00
VS cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 2500000.00
VS cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
VS income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
VS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 160865.00
VS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 11429324.00
VS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 11429324.00
VS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
VS income_statement (annual, 2024-12-31) — Tax Provision: 24226.00
VS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
VS balance_sheet (annual, 2024-12-31) — Total Assets: 3535560.00
VS balance_sheet (annual, 2024-12-31) — Total Capitalization: 11429324.00
VS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3509272.00
VS income_statement (annual, 2024-12-31) — Total Expenses: 4596514.00
VS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 26288.00
VS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 0.00
VS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
VS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -4539226.00
VS income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
VS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
VS balance_sheet (annual, 2024-12-31) — Working Capital: 3509272.00
VS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1363885.00
VS income_statement (quarterly, 2025-03-31) — +Total Revenue: 199347.00
VS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2062.00
VS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 4901677.00
VS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.20
VS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3065914.00
VS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 150953018.00
VS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2432219.00
VS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2432219.00
VS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 2432219.00
VS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
VS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -641445.00
VS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -24226.00
VS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 173258.00
VS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 0.00
VS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 149032.00
VS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -641445.00
VS balance_sheet (quarterly, 2025-03-31) — Common Stock: 150953018.00
VS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10841328.00
VS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 8223.00
VS balance_sheet (quarterly, 2025-03-31) — Current Assets: 2728607.00
VS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2062.00
VS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 4901677.00
VS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.20
VS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -961746.00
VS income_statement (quarterly, 2025-03-31) — EBIT: -1172761.00
VS income_statement (quarterly, 2025-03-31) — EBITDA: -1172761.00
VS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 7750.00
VS cash_flow (quarterly, 2025-03-31) — End Cash Position: 2432219.00
VS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -641445.00
VS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 326409.00
VS income_statement (quarterly, 2025-03-31) — Gross Profit: 191124.00
VS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 10841328.00
VS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
VS balance_sheet (quarterly, 2025-03-31) — Minority Interest: -8114783.00
VS income_statement (quarterly, 2025-03-31) — Minority Interests: 194731.00
VS income_statement (quarterly, 2025-03-31) — Net Income: -961746.00
VS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -961746.00
VS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1156477.00
VS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -961746.00
VS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -961746.00
VS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1156477.00
VS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1156477.00
VS cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
VS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 10841328.00
VS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1172761.00
VS income_statement (quarterly, 2025-03-31) — Normalized Income: -961746.00
VS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -641445.00
VS income_statement (quarterly, 2025-03-31) — Operating Income: -1172761.00
VS income_statement (quarterly, 2025-03-31) — Operating Revenue: 199347.00
VS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4901677.00
VS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 296388.00
VS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 326409.00
VS income_statement (quarterly, 2025-03-31) — Other Income Expense: 16284.00
VS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 16284.00
VS balance_sheet (quarterly, 2025-03-31) — Payables: 2062.00
VS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2062.00
VS income_statement (quarterly, 2025-03-31) — Pretax Income: -1156477.00
VS cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
VS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 8223.00
VS income_statement (quarterly, 2025-03-31) — Research And Development: 6149.00
VS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -140438099.00
VS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1357736.00
VS balance_sheet (quarterly, 2025-03-31) — Share Issued: 4901677.00
VS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 366000.00
VS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10841328.00
VS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 10841328.00
VS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
VS income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
VS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
VS balance_sheet (quarterly, 2025-03-31) — Total Assets: 2728607.00
VS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 10841328.00
VS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2726545.00
VS income_statement (quarterly, 2025-03-31) — Total Expenses: 1372108.00
VS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2062.00
VS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 0.00
VS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
VS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1172761.00
VS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2726545.00
VS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1032977.00
VS income_statement (quarterly, 2025-06-30) — +Total Revenue: 1980000.00
VS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 34187.00
VS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 330000.00
VS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4901677.00
VS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.14
VS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2432219.00
VS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 150974494.00
VS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1682256.00
VS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1682256.00
VS balance_sheet (quarterly, 2025-06-30) — Cash Financial: 1682256.00
VS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -867527.00
VS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 32125.00
VS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 116411.00
VS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1980000.00
VS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -1831464.00
VS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -867527.00
VS balance_sheet (quarterly, 2025-06-30) — Common Stock: 150974494.00
VS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 11652703.00
VS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8222.00
VS balance_sheet (quarterly, 2025-06-30) — Current Assets: 3842233.00
VS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 34187.00
VS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4927369.00
VS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.14
VS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 672335.00
VS income_statement (quarterly, 2025-06-30) — EBIT: 938801.00
VS income_statement (quarterly, 2025-06-30) — EBITDA: 938801.00
VS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 117564.00
VS cash_flow (quarterly, 2025-06-30) — End Cash Position: 1682256.00
VS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -867527.00
VS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 443973.00
VS income_statement (quarterly, 2025-06-30) — Gross Profit: 1971778.00
VS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 11652703.00
VS balance_sheet (quarterly, 2025-06-30) — Minority Interest: -7844657.00
VS income_statement (quarterly, 2025-06-30) — Minority Interests: -270126.00
VS income_statement (quarterly, 2025-06-30) — Net Income: 672335.00
VS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 672335.00
VS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 942461.00
VS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 672335.00
VS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 672335.00
VS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 942461.00
VS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 942461.00
VS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 11652703.00
VS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 938801.00
VS income_statement (quarterly, 2025-06-30) — Normalized Income: 672335.00
VS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -867527.00
VS income_statement (quarterly, 2025-06-30) — Operating Income: 938801.00
VS income_statement (quarterly, 2025-06-30) — Operating Revenue: 1980000.00
VS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4901677.00
VS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 179977.00
VS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 443973.00
VS income_statement (quarterly, 2025-06-30) — Other Income Expense: 3660.00
VS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 3660.00
VS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1650000.00
VS balance_sheet (quarterly, 2025-06-30) — Payables: 34187.00